نتایج جستجو برای: blaper

تعداد نتایج: 85  

Journal: :iranian red crescent medical journal 0
atena amiri department of microbiology and immunology, school of medicine, kashan university of medical sciences, kashan, ir iran farzaneh firoozeh department of microbiology and immunology, school of medicine, kashan university of medical sciences, kashan, ir iran; department of microbiology and immunology, school of medicine, kashan university of medical sciences, kashan, ir iran. tel/fax: +98-3155540021 rezvan moniri department of microbiology and immunology, school of medicine, kashan university of medical sciences, kashan, ir iran mohammad zibaei department of parasitology and mycology, school of medicine, alborz university of medical sciences, karaj, ir iran

conclusions the prevalence of esbl-producing klebsiella strains in shahid-beheshti hospital in kashan has increased. the study concluded that there was a high prevalence of the blactx-m type gene among esbl positive isolates. patients and methods one hundred klebsiella spp. were isolated from clinical specimens of hospitalized patients at shahid-beheshti hospital from december 2012 to november ...

ژورنال: :مجله دانشگاه علوم پزشکی اراک 0
مجید اسلامی majid eslami department of bacteriology, faculty of medical sciences, tarbiat modares university, tehran, iranگروه باکتری شناسی، دانشکده پزشکی، دانشگاه تربیت مدرس، تهران، ایران شهین نجار پیرایه shahin najar peerayeh department of bacteriology, faculty of medical sciences, tarbiat modares university, tehran, iranگروه باکتری شناسی، دانشکده پزشکی، دانشگاه تربیت مدرس، تهران، ایرانسازمان اصلی تایید شده: دانشگاه تربیت مدرس (tarbiat modares university)

زمینه و هدف: آنزیم‎های بتالاکتاماز tem، vebو perاز آنزیم‎های بتالاکتاماز وسیع‎الطیف هستند که قادر به هیدرولیز پنی‎سیلین‎ها، سفالوسپورین‎ها و آزترئونام می‎باشند. هدف از این بررسی تعیین فراوانی اشریشیاکلی‎های تولیدکننده بتالاکتاماز وسیع‎الطیف و ارزیابی مولکولی بتالاکتامازهای tem، per و veb در سویه‎های باکتری اشیرشیاکلی بود. مواد و روش‎ها: تعداد 200 سویه اشریشیاکلی از نمونه‎های کلینیکی جدا شد و حس...

Journal: :Antimicrobial agents and chemotherapy 2013
V M Blanco L J Rojas E De La Cadena J J Maya R D Camargo A Correa J P Quinn M V Villegas

Carbapenemases are a growing concern worldwide since they threaten the efficacy of carbapenems, the most potent -lactam antibiotics. Nonmetallocarbapenemase class A (NMC-A) was identified in 1990 from a clinical isolate of Enterobacter cloacae, and since its first report in France (1), this rare enzyme has been found only in the United States (Seattle, WA, and New York, NY), Argentina, and Finl...

Journal: :Journal of clinical microbiology 2012
Radosław Izdebski Janusz Fiett Waleria Hryniewicz Marek Gniadkowski

Acinetobacter baumannii is currently one of the key nosocomial pathogens causing severe infections; of special concern is its resistance to expanded-spectrum cephalosporins (ESCs) and carbapenems, often associated with the few so-called European clones (6, 7, 19). It has two natural -lactamases, an AmpC-like enzyme (Acinetobacter-derived cephalosporinase [ADC]) (10) and a carbapenem-hydrolyzing...

2015
Abdulmajeed G. Kraiem Abdulaziz Zorgani Omar Elahmer Adnene Hammami Basma M. Chaaben Khalifa Sifaw Ghenghesh

To the Editor Carbapenems (i.e. ertapenem, imipenem, meropenem, and doripenem) are second line antimicrobials reserved to treat serious infections, including those caused by Gramnegative bacilli (GNB) producing extended-spectrum b-lactamses (ESBLs). ESBLs mediate resistance among GNB to b-lactam drugs, including third generation cephalosporins. Emergence of carbapenemases-producing GNB (mainly ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید